The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step

Issued on behalf of Avaí Bio, Inc. USANewsGroup.com VANCOUVER, BC, March 31, 2026 /PRNewswire/ -- The FDA has approved more than 40 cell and gene therapy products. The regenerative medicine market is projected to reach $578 billion by 2033. Cell therapy alone surpassed $8.2 billion this...